Bookbuilding IPO | ₹121 Cr | Listed at BSE, NSE | Tue, Aug 26, 2025 - Fri, Aug 29, 2025
Anlon Healthcare IPO is a book build issue of ₹121.03 crores. The issue is entirely a fresh issue of 1.33 crore shares of ₹121.03 crore.
Anlon Healthcare IPO bidding started from Aug 26, 2025 and ended on Aug 29, 2025. The allotment for Anlon Healthcare IPO was finalized on Sep 1, 2025. The shares got listed on BSE, NSE on Sep 3, 2025.
Anlon Healthcare IPO price band is set at ₹91 per share. The lot size for an application is 164. The minimum amount of investment required by an retail is ₹14,924 (164 shares) (based on upper price). The lot size investment for sNII is 14 lots (2,296 shares), amounting to ₹2,08,936, and for bNII, it is 68 lots (11,152 shares), amounting to ₹10,14,832.
Interactive Financial Services Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue.
Refer to Anlon Healthcare IPO RHP for detailed Information.
IPO Open
Tue, Aug 26, 2025
IPO Close
Fri, Aug 29, 2025
Issue Price
₹91 per share
Market Cap (Pre-IPO)
₹483.68 Cr
| IPO Date | 26 to 29 Aug, 2025 |
| Listed on | Wed, Sep 3, 2025 |
| Face Value | ₹10 per share |
| Price Band | ₹86 to ₹91 |
| Issue Price | ₹91 per share |
| Lot Size | 164 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 1,33,00,000 shares (agg. up to ₹121 Cr) |
| Fresh Issue | 1,33,00,000 shares (agg. up to ₹121 Cr) |
| Share Holding Pre Issue | 3,98,51,500 shares |
| Share Holding Post Issue | 5,31,51,500 shares |
| BSE Script Code / NSE Symbol | 544497 / AHCL |
| ISIN | INE0Y8W01017 |
Anlon Healthcare IPO offers total 1,33,00,000 shares. Out of which 99,75,000 (75.00%) allocated to QIB, 19,95,000 (15.00%) allocated to NII 13,30,000 (10.00%) allocated to RII.
| Investor Category | Shares Offered | Max Allottees |
|---|---|---|
| QIB Shares Offered | 99,75,000 (75.00%) | NA |
| NII (HNI) Shares Offered | 19,95,000 (15.00%) | NA |
| − bNII > ₹10L | 13,30,000 (10.00%) | 579 |
| − sNII < ₹10L | 6,65,000 (5.00%) | 289 |
| Retail Shares Offered | 13,30,000 (10.00%) | 8,109 |
| Total Shares Offered | 1,33,00,000 (100.00%) |
Investors can bid for a minimum of 164 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 164 | ₹14,924 |
| Retail (Max) | 13 | 2,132 | ₹1,94,012 |
| S-HNI (Min) | 14 | 2,296 | ₹2,08,936 |
| S-HNI (Max) | 67 | 10,988 | ₹9,99,908 |
| B-HNI (Min) | 68 | 11,152 | ₹10,14,832 |
Incorporated in 2013, Anlon Healthcare Limited is a chemical manufacturing company engaged in manufacturing of Pharma Intermediates and active pharmaceutical ingredients (APIs).
The company manufactures high-purity pharmaceutical intermediates (for API production) and active pharmaceutical ingredients (used in formulations for medicines, nutraceuticals, personal care, and animal health products).
The company offers pharmaceutical intermediates, APIs for medicines, nutraceuticals, personal care, and veterinary products, all manufactured following Indian and international pharmacopeia standards like IP, BP, EP, JP, and USP.
In addition to manufacturing Pharma Intermediates and APIs to global standards, the company now offers custom manufacturing for complex chemicals, exceeding purity standards and reducing impurities to meet specific customer needs.
The company has received Drug Master File (DMF) approval from ANVISA, NMPA, and PMDA for loxoprofen sodium dihydrate and loxoprofen acid APIs. The company has filed 21 DMFs with global authorities and is in the process of filing for Ketoprofen and Dexketoprofen Trometamol approvals.
The company ensures product quality through rigorous testing, analysis, and process improvements. Supported by four labs, the 34-member team, including 24 science graduates, ensures products meet customer and industry standards.
The company's product portfolio consists of sixty-five (65) commercialised products and twenty-eight (28) products at pilot stage and forty-nine (49) products at laboratory testing stage/ laboratory scale stage.
Products:
Competitive Strengths:
Anlon Healthcare Ltd.'s revenue increased by 81% and profit after tax (PAT) rose by 112% between the financial year ending with March 31, 2025 and March 31, 2024.
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 181.30 | 128.00 | 111.55 |
| Total Income | 120.46 | 66.69 | 113.12 |
| Profit After Tax | 20.52 | 9.66 | 5.82 |
| EBITDA | 32.38 | 15.57 | 12.66 |
| NET Worth | 80.42 | 21.03 | 7.37 |
| Reserves and Surplus | 40.57 | 5.03 | -4.63 |
| Total Borrowing | 58.35 | 74.56 | 66.39 |
| Amount in ₹ Crore | |||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding capital expenditure requirements for Proposed Expansion | 30.72 |
| 2 | Full or part repayment and/or prepayment of certain outstanding secured borrowingssecured borrowing (term loan)availed by the Company | 5.00 |
| 3 | Funding the working capital requirements of the Company | 43.15 |
| 4 | General corporate purposes | 27.03 |
| Total | 105.90 |
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 40.45% |
| ROCE | 21.93% |
| Debt/Equity | 0.73 |
| RoNW | 25.51% |
| PAT Margin | 17.06% |
| EBITDA Margin | 26.88% |
| Price to Book Value | 4.51 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 5.15 | 3.86 |
| P/E (x) | 17.67 | 23.57 |
| Promoter Holding | 70.26% | 52.68% |
| Market Cap | ₹483.68 Cr. |
The Anlon Healthcare IPO is subscribed 7.12 times on August 29, 2025 5:04:36 PM (Day 3). The public issue subscribed 47.26 times in the retail category, 1.07 times in the QIB category, and 10.61 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| QIB (Ex Anchor) | 1.07 | 99,75,000 | 1,06,89,028 |
| NII | 10.61 | 19,95,000 | 2,11,61,412 |
| bNII (bids above ₹10L) | 7.56 | 13,30,000 | 1,00,59,924 |
| sNII (bids below ₹10L) | 16.69 | 6,65,000 | 1,11,01,488 |
| Retail | 47.26 | 13,30,000 | 6,28,57,920 |
| Total | 7.12 | 1,33,00,000 | 9,47,08,360 |
Total Application : 3,34,669
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Fees payable to the BRLM and commissions (including underwriting commission, brokerage and selling commission) | 7.85 |
| 2 | Commission/processing fee for SCSBs, Sponsor Bank(s) and Bankers to the Issue and fee payable to the Sponsor Bank for Bids made by RIBs. Brokerage, underwriting commission and selling commission and bidding charges for Members of the Syndicate, Registered Brokers, CRTAs and CDP | 1.21 |
| 3 | Advertising and marketing expenses | 0.48 |
| 4 | Fee payable to auditors, consultants and market research firms | 0.85 |
| 5 | Listing fees, SEBI, BSE and NSE processing fees, book building software fees and other regulatory expenses | 2.41 |
| 6 | Printing and distribution of stationary | 0.59 |
| 7 | Fees payable to Registrar to the Issue | 0.59 |
| 8 | Fees payable to Legal Counsel | 0.71 |
| 9 | Fees payable to Monitoring Agency | 0.12 |
| 10 | Miscellaneous | 0.32 |
| Price Details | BSE | NSE |
|---|---|---|
| Final Issue Price | ₹91.00 | ₹91.00 |
| Open | ₹91.00 | ₹92.00 |
| Low | ₹89.00 | ₹90.78 |
| High | ₹92.00 | ₹92.50 |
| Last Trade | ₹91.66 | ₹91.73 |
Lead Manager Reports
Anlon Healthcare IPO is a main-board IPO of 1,33,00,000 equity shares of the face value of ₹10 aggregating up to ₹121 Crores. The issue is priced at ₹91 per share. The minimum order quantity is 164.
The IPO opens on Tue, Aug 26, 2025, and closes on Fri, Aug 29, 2025.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Anlon Healthcare IPO using UPI as a payment gateway. Zerodha customers can apply in Anlon Healthcare IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Anlon Healthcare IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Anlon Healthcare IPO opens on Tue, Aug 26, 2025 and closes on Fri, Aug 29, 2025.
Anlon Healthcare IPO lot size is 164, and the minimum amount required for application is ₹14,924.
You can apply in Anlon Healthcare IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Anlon Healthcare IPO will be done on Monday, September 1, 2025, and the allotted shares will be credited to your demat account by Tue, Sep 2, 2025. Check the Anlon Healthcare IPO allotment status.
The Anlon Healthcare IPO listing date is on Wed, Sep 3, 2025.
